Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Tax Provision
Abbott Laboratories
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Tax Provision
-$908m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-19%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Tax Provision
-$237m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
Boston Scientific Corp
NYSE:BSX
|
Tax Provision
-$393m
|
CAGR 3-Years
-481%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Tax Provision
-$198.7m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Tax Provision
-$508m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Tax Provision
-$71.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
See Also
What is Abbott Laboratories's Tax Provision?
Tax Provision
-908m
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Tax Provision amounts to -908m USD.
What is Abbott Laboratories's Tax Provision growth rate?
Tax Provision CAGR 10Y
-19%
Over the last year, the Tax Provision growth was 24%. The average annual Tax Provision growth rates for Abbott Laboratories have been -13% over the past three years , -16% over the past five years , and -19% over the past ten years .